Default: Molecular Cancer Therapeutics

ISSN:

Journal Home

Journal Guideline

Molecular Cancer Therapeutics Q1 Unclaimed

American Association for Cancer Research Inc. United States
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Molecular Cancer Therapeutics is a journal indexed in SJR in Oncology and Cancer Research with an H index of 173. It has a price of 3000 €. It has an SJR impact factor of 2,717 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 2,717.

Molecular Cancer Therapeutics focuses its scope in these topics and keywords: inhibitor, potent, cancer, resistance, protein, cells, vitro, inhibition, activity, receptor, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Price

3000 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Molecular Cancer Therapeutics

2,717

SJR Impact factor

173

H Index

244

Total Docs (Last Year)

747

Total Docs (3 years)

10829

Total Refs

4623

Total Cites (3 years)

726

Citable Docs (3 years)

5,27

Cites/Doc (2 years)

44,38

Ref/Doc

Aims and Scope


inhibitor, potent, cancer, resistance, protein, cells, vitro, inhibition, activity, receptor, kinase, breast, antitumor, inhibits, pi, inhibitors, growth, sensitivity, p, ir, induces, igfr, hepatocellular, therapeutic,

Comments

No comments ... Be the first to comment!

FAQS